With a $2 million grant from the National Institutes of Health, scientists from the University of Rochester Medical Center and Rochester Institute of Technology will enroll up to 300 people at risk ...
OMRON Healthcare has secured De Novo authorisation from the US Food and Drug Administration (FDA) for new home blood pressure monitors with AI-powered atrial fibrillation (AFib) detection feature.
Medical Device Network on MSN
CardiaCare secures seed extension funding for AFib clinical studies
The financing aims to bolster CardiaCare’s clinical programme for AFib indications.
In October 2024, Omron Healthcare received de novo authorisation from the US Food and Drugs Administration (FDA) to market its new home blood pressure monitors equipped with AI-powered atrial ...
The Food and Drug Administration (FDA) has approved the Apple Watch for detecting atrial fibrillation (AFib). However, it cannot provide a diagnosis. Anyone who suspects they have AFib should seek a ...
A wearable heart monitor raises the detection rate of the dangerous irregular heartbeat known as atrial fibrillation (A-fib) by more than 50%, a new study finds. Unfortunately, there was no increase ...
The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients for atrial fibrillation without relying on the electrical signals of the ...
MADRID -- Remote screening yielded new cases of atrial fibrillation (Afib or AF) in the general population that otherwise would have gone undetected and untreated, according to the AMALFI trial in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results